ReviewBMC medicine2014

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials.

Pernelle Lavaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.